MediPurpose Inc., incorporated in November 2000, is the United States sales, marketing and distribution subsidiary of MediPurpose Pte Ltd for customers in the United States, Canada, Central and South America. In 2003, Frost and Sullivan awarded its 2003 Distribution Leadership Award to MediPurpose for the company's skillful development of key alliances with distributors and group purchasing organizations throughout the U.S.

At the end of 2003 with U.S. sales topping $6.3 million, MediPurpose began to expand its business into Europe, opening an office in London. In March 2004, the company was awarded a contract to supply its SurgiLance Safety Lancets to the NHS, establishing MediPurpose as a significant player within the UK's safety lancet market.

By the end of 2005, the company had sold over 330 million SurgiLance Safety Lancets since the product first launched in September 2000, enough for every person in the U.S. The company has achieved success as one of the top market leaders in the US safety lancet market, and has developed solid channels of distribution and GPO relationships.

The company changed its name in November 2006 to MediPurpose with a view to expanding its product range. In line with the new corporate identity, the company changed the name of the One-Step Safety Lancet to the SurgiLance Safety Lancet.

SurgiLance Safety Lancets are ISO 9000 certified,
CE certified and meet all FDA requirements.